Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...

For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

When asked about each segment of ESG, almost all of the surveyed groups, 94%, said that the impact a pharma has on society is ...

Gilead Sciences Inc. closed 0.11% below its 52-week high of $112.11, which the company reached on February 25th.

Piper Sandler analyst Joseph Catanzaro maintained a Buy rating on Revolution Medicines (RVMD – Research Report) today and set a price target of ...

Gilead Sciences' Q4 2024 results, driven by HIV drug demand and Trodelvy growth, make it a compelling choice for long-term ...

Alcoholic and non-alcoholic fatty liver disease (NAFLD) are well-known risk factors for colorectal cancer (CRC). NAFLD has ...

Salesforce is expected to report fourth-quarter results after the market closes Wednesday, with analysts largely bullish on ...

Dr Hamied, as the scientist-entrepreneur is better known, is not particularly concerned about the impact of tariffs on ...

Concerned Citizens of Morrow County held a community meeting Feb. 19 regarding the Crossroads Solar Project being planned ...

David Winand, financial advisor for Edward Jones, was the speaker at the Morrow Chamber of Commerce “Lunch and Learn” meeting ...